Pay in 4 interest-free payments of $5.64 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Phase 2b doses were 0.25 to 1.0 mg daily, which at a 2.5 mg/ml concentration means 0.1 to 0.4 ml per injection, conveniently measurable on a 1 ml insulin syringe
Large real-world datasets have not demonstrated increased thyroid cancer risk in treated patients
Sermorelin was previously FDA-approved under the brand name Geref, both as a diagnostic agent for GH deficiency (Geref Diagnostic, approved 1997) and as a therapeutic agent for pediatric idiopathic GH deficiency
The resistance of Th2 cells to FasL-mediated apoptosis has been attributed to the augmented baseline activities of FLIP, TRAIL, and NF-kB in these cells
Dose adjustments may be made by your provider based on response and tolerability
Peptides in New Zealand: access, the law, and what the evidence actually shows
US$ 26.96
US$ 26.45
US$ 27.47
US$ 23.15
